How Bluetongue Virus Enters Host Cells Revealed
Complete the form below to unlock access to ALL audio articles.
Led by Polly Roy, Professor of Virology and Wellcome Trust Senior Investigator at the London School of Hygiene & Tropical Medicine, the research shows the atomic detail of the individual components of the virus particle, and how these function biologically at different levels of acidity (pH).
The team used cutting-edge cryo electron microscopy from the Electron Imaging Center for Nanomachines, led by Dr Hong Zhou, at UCLA’s California NanoSystems Institute. With this technology they demonstrated how the virus enters cells to initiate infection via a two-stage process, and how the different molecular components fit together. This new understanding will enable researchers to develop new vaccines with broader protection against BTV and related viruses.
Viruses establishing infection in host cells is a highly coordinated process. The molecular and chemical details are relatively clear for enveloped viruses, such as influenza, HIV and herpes, but up to now the mechanisms for cell entry of non-enveloped viruses, such as BTV and others, had not been well understood.
The researchers discovered that the virus has sensor proteins on its surface that detect changes in the acidity of its environment. When these proteins sense higher acidity caused by proximity to the target cell, the virus unfurls a protein structure that penetrates the outer membrane of the cell and anchors the virus to the cell, causing infection. The team confirmed this mechanism by lowering the acidity around the virus, which caused the membrane-penetrating protein structure to detach and refold, showing its status in high and low pH environments.
Over the past decade Professor Roy has undertaken the first complete molecular understanding of BTV. This includes its replication cycle from virus entry via genome replication to virus assembly and structure, cell-to-cell transmission, and the engagement of the virus particle with the host cell.
Professor Roy said: “We are delighted with these results, which show the virus in the highest possible detail at different pH levels. This represents a key piece in the puzzle and a significant step forward for understanding molecular structures and mechanisms in this family of viruses. We hope it will enable the design of specific anti-viral agents and new and efficient vaccines for the control of bluetongue and related viral infections of animals and humans”.
This work also has promising implications for understanding similar human and animal pathogenic viruses, such as rotaviruses and the Rift Valley fever virus. This research was supported by the National Institutes of Health, the National Science Foundation, the University of California, Los Angeles, and the Wellcome Trust.